Corridome

European ORLADEYO business

Sale October 1, 2025

From an SEC filing dated Oct 1, 2025

  1. European ORLADEYO business agreed to be sold to Neopharmed Gentili, announced on Oct 1, 2025.

    8-K

  2. BofA Securitiesfirm and TD Financial Productsfirm advised the seller.

    8-K

  3. Centerview Partnersfirm advised the buyer.

    8-K

  4. The filing puts the value at $250M.

    8-K

  5. BofA Securitiesfirm also worked on Trivium Packaging B.Vdeal, on Oct 19, 2026.

    8-K

Parties

first 2 of 6

PartyRoleSource
Neopharmed GentiliBuyer8-K
BioCryst PharmaceuticalsSeller8-K

4 more parties

Sign up free to see the first 5, or become a member to see all 6.

Sign up freeBecome a member

Value

KindAmountBasisSource
Disclosed$250Mtransaction value8-K

More deals

first 2 of 13

DateDealFirmsSource
Oct 30, 2026Premier Dealer Holding Corp · SaleTD Financial Products8-K
Oct 29, 2026Maplebear Inc · SaleGoldman Sachs & Co., Centerview Partners8-K

11 more deals

Deals with BofA Securities, TD Financial Products and Centerview Partners.

Sign up free to see the first 5, or become a member to see all 13.

Sign up freeBecome a member

On file

Date as stated
October 1, 20258-K
Filed by
Biocryst Pharmaceuticals Inc (BCRX)8-K
Status
Completed8-K

Browse the register